NewScientist.com News Service, Andy Coghlan

Hopes for treating disease with stem cells from umbilical cord blood has received a major boost, following the discovery of primitive cells with clinical potential matching that of the far more controversial embryonic stem cells (ESCs). The latter are originally derived from human fetuses, which are then destroyed, and have become a major ethical issue, especially in the US...